leadf
logo-loader
viewAminex PLC

Aminex appoints Charles Santos as new chairman

"We have taken the opportunity to rebalance the board of directors with the appointment of two independent directors," said interim chief executive Robert Ambrose.

Aminex PLC - Aminex appoints Charles Santos as new chairman

Aminex PLC (LON:AEX) has appointed Charles Santos as its new non-executive chairman and Tom Mackay as a non-executive director, both with immediate effect.

At the same time, Robert Ambrose returns to his prior role as interim chief executive.

"Following recent changes, we have taken the opportunity to rebalance the board of directors with the appointment of two independent directors," Ambrose said in a statement.

“Charles and Tom are high-quality independent appointees, bringing a range of skills to the Board of Aminex. We warmly welcome Charles and welcome back Tom to the Board and look forward to working with them both."

Santos is presently chief executive and chairman of UIG Energy Inc which is focussed on projects in Central and Southeast Asia. His past 33 years’ experience in the industry span operations in West Africa, the Middle East, and Central, South, and East Asia.

He has important experience handling political and commercial negotiations including, for example, negotiations on the Afghan portion of the Turkmen-Afghan-Pakistan-India gas pipeline for a consortium of international energy companies. In the late 1980s and early 1990s he was a special advisor in the United Nations, where his involvement included UN Peace missions in Afghanistan and Tajikistan.

Mackay, meanwhile, was previously appointed as a director of Aminex in 2014 and was recently interim chief executive between April 2019 and April 2020.

Quick facts: Aminex PLC

Price: 0.961 GBX

LSE:AEX
Market: LSE
Market Cap: £36.24 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Aminex PLC named herein, including the promotion by the Company of Aminex PLC in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Market Report: FTSE gets an injection of optimism from US Remdesivir approval

FTSE 100 got a lift as a first treatment for COVID-19, remdesivir, was approved in the US. London’s leading index added 41 points to 5,826 in early dealings. Gilead Inc (NASDAQ:GILD) produces remdesivir and it is said to cut COVID-19 recovery times by five days. According to the World Health...

1 week ago

2 min read